These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36915392)

  • 1. Vessels That Encapsulate Tumor Clusters (VETC) Predict cTACE Response in Hepatocellular Carcinoma.
    Lin C; He Y; Liu M; Wu A; Zhang J; Li S; Li S; Cao Q; Liu F
    J Hepatocell Carcinoma; 2023; 10():383-397. PubMed ID: 36915392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.
    Akiba J; Nakayama M; Kondo R; Kusano H; Ogasawara S; Mihara Y; Tanigawa M; Tsutsui K; Yano Y; Miyazaki D; Tokisawa S; Mitsuhashi T; Nomura H; Sanada S; Sakai H; Hisaka T; Yano H
    In Vivo; 2024; 38(2):640-646. PubMed ID: 38418151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.
    Fang JH; Xu L; Shang LR; Pan CZ; Ding J; Tang YQ; Liu H; Liu CX; Zheng JL; Zhang YJ; Zhou ZG; Xu J; Zheng L; Chen MS; Zhuang SM
    Hepatology; 2019 Sep; 70(3):824-839. PubMed ID: 30506570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
    Lin W; Lu L; Zheng R; Yuan S; Li S; Ling Y; Wei W; Guo R
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17231-17239. PubMed ID: 37801135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.
    Renne SL; Woo HY; Allegra S; Rudini N; Yano H; Donadon M; Viganò L; Akiba J; Lee HS; Rhee H; Park YN; Roncalli M; Di Tommaso L
    Hepatology; 2020 Jan; 71(1):183-195. PubMed ID: 31206715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation.
    Dennis C; Prince DS; Moayed-Alaei L; Remash D; Carr-Boyd E; Bowen DG; Strasser SI; Crawford M; Pulitano C; Kench J; McCaughan GW; McKenzie C; Liu K
    Front Oncol; 2022; 12():997093. PubMed ID: 36387254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
    Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Feng Z; Li H; Zhao H; Jiang Y; Liu Q; Chen Q; Wang W; Rong P
    Radiology; 2021 Jul; 300(1):219-229. PubMed ID: 33973839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
    Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
    Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion.
    Lu L; Wei W; Huang C; Li S; Zhong C; Wang J; Yu W; Zhang Y; Chen M; Ling Y; Guo R
    Hepatol Int; 2021 Jun; 15(3):651-662. PubMed ID: 33835379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.
    Pan J; Huang H; Zhang S; Zhu Y; Zhang Y; Wang M; Zhang C; Zhao YC; Chen F
    Eur Radiol; 2024 Jul; ():. PubMed ID: 38992109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Poor Prognosis Factor in Patients with Hepatocellular Carcinoma: An Analysis of Microvessel Density.
    Huang CW; Lin SE; Huang SF; Yu MC; Tang JH; Tsai CN; Hsu HY
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.
    Zhu ZY; Yuan M; Yang PP; Xie B; Wei JZ; Qin ZQ; Qian Z; Wang ZY; Fan LF; Qian JY; Tan YL
    World J Surg Oncol; 2022 Jun; 20(1):192. PubMed ID: 35689233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma.
    Wang JH; Li XS; Tang HS; Fang RY; Song JJ; Feng YL; Guan TP; Ruan Q; Wang J; Cui SZ
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4163-4172. PubMed ID: 36050540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
    Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study.
    Wen P; Chen SD; Wang JR; Zeng YH
    Oncol Res; 2019 May; 27(5):583-592. PubMed ID: 31053181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis.
    Shi Q; Liu J; Li T; Zhou C; Wang Y; Huang S; Yang C; Chen Y; Xiong B
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101893. PubMed ID: 35247625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE.
    Hu B; Zhong BY; Zhang L; Dai C; Li W; Shen J; Huang P; Zhang S; Li Z; Ni CF
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1460-1467. PubMed ID: 32500251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence.
    He C; Zhou Z; Jiang H; Yin Z; Meng S; Zhang J; Huang P; Xu K; Bian L; Xiao Z; Wang J
    J Cancer; 2017; 8(1):39-47. PubMed ID: 28123596
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history.
    Tang J; Huang Z; Xu J; Lv Q; Wang P
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101814. PubMed ID: 34597848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.